The cutoff value of post-HMGB1 (i.e., the urine HMGB1 level after application of RIPC) in the RIPC cohort, for being protected from AKI, was 46.2 ng/mL (sensitivity 0.69, specificity 0.76). This evidence concerns the gene HMGB1 and acute kidney injury.